Materias dentro de su búsqueda.
Mostrando 841 - 860 Resultados de 6,403 Para Buscar '"European Union"', tiempo de consulta: 0.81s Limitar resultados
  1. 841
    “…We examined the antimicrobial susceptibility/resistance of gonococcal isolates (n = 15,803) collected across 27 European Union/European Economic Area (EU/EEA) countries in 2009–2016, in conjunction to epidemiological and clinical data of the corresponding patients, to elucidate associations between antimicrobial susceptibility/resistance and patients’ gender, sexual orientation and anatomical site of infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients’ gender, sexual orientation and anatomical site of infection, 2009–2016
  2. 842
    por van der Kooi, Tjallie, Lepape, Alain, Astagneau, Pascal, Suetens, Carl, Nicolaie, Mioara Alina, de Greeff, Sabine, Lozoraitiene, Ilma, Czepiel, Jacek, Patyi, Márta, Plachouras, Diamantis, Sips, Meander, Edlinger-Stanger, Maximilian, Hiesmayr, Michael, Denolf, Joke, Nauwynck, Marc, Si Ali, Amine, Jannière-Nartey, Caroline, Munier-Marion, Elodie, Grillet, Guillaume, Robaux, Marie-Aline, Agodi, Antonella, Castiglione, Giacomo, Astuto, Marinella, Durì, Davide, Kisieliene, Ieva, Varkila, Meri, van Ooik, Paula, Kuijper, Ed, Crobach, Monique, Biesiada, Grażyna, Carvalho, Clara, Tapadinhas, Camila, Corte-Real, Rita, Cardoso, Sofia, Barroso, Maria, Castro, Heloisa, Pinheiro Marques, Ana Josefina, Pascoalinho, Dulce, Ribeiro, Adriana, Freitas, Filomena, Gimeno Costa, J Ricardo, Casals, F Xavier Nuvials, Pugh, Richard, Savey, Anne, Enoch, David A., de Jonge, Evert, Winkler, Heinz, DeWaele, Jan, Burns, Karen, Palomar Martinez, Mercedes, Leistner, Rasmus, Hopkins., Susan
    Publicado 2021
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018
  3. 843
    “…Against this backdrop, we assessed the absolute and relative drug lags of the Indian regulator relative to three regulators in mature markets, namely United States (US), European Union (EU), and Japan. METHODS: International nonproprietary names were used to identify new drugs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)
  4. 844
    por Brice, Maximilien
    Publicado 2014
    “…Mr Nopadol Gunavibool Ambassador to the Kingdom of Belgium, Luxembourg and the European Union Kingdom of Thailand…”
    Enlace del recurso
    22 May 2014 - Ambassador of the Kingdom of Thailand to the Kingdom of Belgium, Luxembourg and the European Union N. Gunavibool signing the guest book with CERN Deputy Head of International Relations E. Tsesmelis.
  5. 845
    “…After 2002, the WHO released the WHA55.23 Resolution and the Global Strategy which produced several changes in policymaking, but with no subsequent analyses of the impact of these changes in European Union (EU) policymaking while examining PIA prevalence. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A retrospective analysis of policy development on compliance with World Health Organization’s physical activity recommendations between 2002 and 2005 in European Union adults: closing the gap between research and policy
  6. 846
    “…In 2016, the Netherlands was required to introduce new European Union (EU)’s (pictorial) tobacco health warnings. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    How the New European Union’s (Pictorial) Tobacco Health Warnings Influence Quit Attempts and Smoking Cessation: Findings from the 2016–2017 International Tobacco Control (ITC) Netherlands Surveys
  7. 847
    “…METHODS: Using data from the 2012 European Union Agency for Fundamental Rights survey on violence against women we applied MAIHDA to analyse experiences of physical and sexual IPV among 42 000 women living in the EU. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Does country-level gender equality explain individual risk of intimate partner violence against women? A multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) in the European Union
  8. 848
    por de Hollander, Ellen
    Publicado 2022
    “…This includes reliable and valid prevalence data of physical activity (PA) that can be compared across European Union Member States populations regardless of the type of measurement instrument used. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    S08-1 Comparing physical activity measurement instruments across member states by means of a conversion factor: European Union Physical Activity and Sport Monitoring System (EUPASMOS) project
  9. 849
    por Vähä-Ypyä, Henri
    Publicado 2022
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    S08-3 Physical activity, sedentary behavior and sleep-time of Eupasmos-project participants in 16 European countries: European Union Physical Activity and Sport Monitoring System (EUPASMOS) project
  10. 850
    “…OBJECTIVE: This double-blind, multicenter, parallel-group, phase III study aimed to establish equivalent efficacy between CT-P16 and European Union-approved reference bevacizumab (EU-bevacizumab) in patients with metastatic or recurrent non-squamous non-small cell lung cancer (nsNSCLC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial
  11. 851
    por Peñalva, Germán, Crespo-Robledo, Paloma, Molvik, Mari, López-Navas, Antonio, Kacelnik, Oliver, Cisneros, José Miguel, Buhmann, Vera, Hlava, Anton, Hunjak, Blaženka, Ivanko, Pero, Škoda, Anamarija, Žemličková, Helena, Mackova, Barbora, Skovgaard, Sissel, Sönksen, Ute Wolff, Zanuzdana, Arina, Eckmanns, Tim, Vatopoulos, Alkiviadis, Polemis, Michalis, Martinelli, Domenico, Fortunato, Francesca, Dambrauskiene, Asta, Valinteliene, Rolanda, Olczak-Pieńkowska, Anna, Żabicka, Dorota, Rodrigues, Maria, Pereira, Nuno, Neves, Isabel, Lepe, José Antonio, Valencia, Raquel, Gil-Navarro, María Victoria, Oliver-Palomo, Antonio, Periañez-Parraga, Leonor del Mar, Rojo-Molinero, Estrella, Oliva, Glòria, Massanes, Marta, Izquierdo-Palomares, José Manuel, Aranguren, Ainhoa, Rausell-Rausell, Víctor José, López-Acuña, María del Pilar, Gil-Setas, Alberto, Portillo, María Eugenia
    Publicado 2022
    “…AIM: To study the feasibility and scalability of a quarterly AMR/AMU surveillance system in the European Union/European Economic Area (EU/EEA). METHODS: We conducted a longitudinal study within the scope of the EU-JAMRAI project. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A step forward in antibiotic use and resistance monitoring: a quarterly surveillance system pilot in 11 European Union/European Economic Area countries, September 2017 to May 2020
  12. 852
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visibility as a Key Dimension to Better Health-Related Quality of Life and Mental Health: Results of the European Union Funded “ME-WE” Online Survey Study on Adolescent Young Carers in Switzerland
  13. 853
    “…INTRODUCTION: The European Centre for Disease Prevention and Control is developing evidence-based guidance for voluntary screening, treatment and vaccine prevention of infectious diseases for newly arriving migrants to the European Union/European Economic Area. The objective of this systematic review protocol is to guide the identification, appraisal and synthesis of the best available evidence on prevention and assessment of the following priority infectious diseases: tuberculosis, HIV, hepatitis B, hepatitis C, measles, mumps, rubella, diphtheria, tetanus, pertussis, poliomyelitis (polio), Haemophilus influenza disease, strongyloidiasis and schistosomiasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems
  14. 854
    por Berteletti, Florence
    Publicado 2017
    “…While there are certainly good reasons to be optimistic about the impact of these instruments in the public health sphere, the experience of the FCTC’s implementation in the context of the European Union (EU) shows that further efforts are still necessary for its full potential to be realised. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reaching Outside the Comfort Zone: Realising the FCTC’s Potential for Public Health Governance and Regulation in the European Union: Comment on "The Legal Strength of International Health Instruments – What It Brings to Global Health Governance?"
  15. 855
    “…RESULTS: Following the implementation of the European Union-Turkey agreement in 2016, healthcare providers in refugee camps reported a shift from acute physical health issues to mental health disorders, and heightened risks of gender-based violence among Syrian refugees. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    “The needs have clearly evolved as time has gone on.”: A qualitative study to explore stakeholders’ perspectives on the health needs of Syrian refugees in Greece following the 2016 European Union-Turkey agreement
  16. 856
    “…The Central European Cooperative Oncology Group (CECOG) and ‘ESMO Open—Cancer Horizons’ roundtable discussion brought together stakeholders from several European Union (EU) countries involved in drug development, drug authorisation and reimbursement or otherwise affected by delayed and unequal access to innovative anticancer drugs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries
  17. 857
    “…Despite the fact that Germany has a relatively low hospital prevalence of HAIs compared with the European Union/European Economic Area (EU/EEA) average, the burden of HAIs in Germany (308.2 DALYs/100,000 population; 95% UI: 221.2–416.3) was higher than the EU/EEA average (290.0 DALYs/100,000 population; 95% UI: 214.9–376.9). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012
  18. 858
    “…The objective of this paper was to synthesize the body of recent evidence on strategies aimed at increasing the uptake and coverage of HIV testing outside of health care settings in the European Union (EU)/European Economic Area (EEA). METHODS: Systematic searches to identify studies describing effective HIV testing interventions and barriers to testing were run in five databases (2010–2017) with no language restrictions; the grey literature was searched for similar unpublished studies (2014–2017). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance
  19. 859
    por Kontoghiorghes, George J.
    Publicado 2021
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs
  20. 860
    “…METHODS: In this double-blind Phase 1 study, healthy volunteers (N = 208) were randomized 1:1:1:1 to a single 3 mg/kg intravenous infusion of HLX04 or reference bevacizumab sourced from the United States (bevacizumab-US), the European Union (bevacizumab-EU) or China (bevacizumab-CN). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers
Herramientas de búsqueda: RSS